An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer 1997 till 2008: a population-based study in the Netherlands

Autor: Marieke W. Louwman, J. J. F. M. Immerzeel, L. Veerbeek, Philip Poortmans, Mieke J. Aarts, Jos W.S. Merkus, Caro C.E. Koning, Henk Struikmans, Jan Willem Coebergh, Marnix L.M. Lybeert, Jan J. Jobsen

Publikováno v: Radiotherapy and Oncology, 100(2), 320-325
Radiotherapy and oncology, 100(2), 320-325. Elsevier Ireland Ltd
Radiotherapy and Oncology, 100(2), 320-325. Elsevier Ireland Ltd

Only scarce data are available on the utilisation rate of primary radiotherapy (RT) for patients with breast cancer. In this study, we compared the use of primary RT for patients with stages I-Ill breast cancer in 4 of the 9 Dutch Comprehensive Cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85ab0ecb79d72079ebca90e8222b8f5
https://hdl.handle.net/1887/98928

Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome

Autor: Aeilko H. Zwinderman, Wilhelmus Quint, J. Davelaar, J. Pomp, J. J. F. M. Immerzeel, Jan Blom, Cees van Krimpen

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 46(2)

Background and purpose : Wildtype p53 protein plays an important role in the cellular response to ionizing radiation and other DNA damaging agents and is mutated in many human tumours. We evaluated the relationship of the immunohistochemically determ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf46c7ea6f945624ce1c7e4bd852f5fb
https://pubmed.ncbi.nlm.nih.gov/9510045